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This article briefly summarizes the epidemiology of the health effects of fine particulate air
pollution, provides an early, somewhat speculative, discussion of the contribution of epidemiology
to evaluating biologic mechanisms, and evaluates who's at risk or is susceptible to adverse health
effects. Based on preliminary epidemiologic evidence, it is speculated that a systemic response
to fine particle-induced pulmonary inflammation, including cytokine release and altered cardiac
autonomic function, may be part of the pathophysiologic mechanisms or pathways linking
particulate pollution with cardiopulmonary disease. The elderly, infants, and persons with chronic
cardiopulmonary disease, influenza, or asthma are most susceptible to mortality and serious
morbidity effects from short-term acutely elevated exposures. Others are susceptible to less
serious health effects such as transient increases in respiratory symptoms, decreased lung
function, or other physiologic changes. Chronic exposure studies suggest relatively broad
susceptibility to cumulative effects of long-term repeated exposure to fine particulate pollution,
resulting in substantive estimates of population average loss of life expectancy in highly polluted
environments. Additional knowledge is needed about the specific pollutants or mix of pollutants
responsible for the adverse health effects and the biologic mechanisms involved. Key words: air
pollution, cardiopulmonary disease, health effects, life expectancy, particulate pollution, review.
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It has long been known, or at least suspected,
that there are adverse health effects associated
with ambient air pollution (1). Extreme air
pollution episodes in the 1930s-1950s were
associated with dramatically elevated cardio-
pulmonary morbidity and mortality.
Evidence ofserious health effects provided by
these episodes spurred a growing concern
about air pollution and in the United States
during the 1950s through early 1970s, there
was a series oflegislative efforts related to try-
ing to control air pollution. Current air pollu-
tion legislation is based largely on the 1970
Clean Air Act and 1990 Amendments to this
act (2). The amended Clean Air Act man-
dated national ambient air quality standards
for pollutants that are relatively common and
widespread but may reasonably be anticipated
to endanger public health. Six pollutants that
met these basic criteria (criteria pollutants)
were eventually selected, including particulate
matter (PM), sulfur dioxide, nitrogen diox-
ide, carbon monoxide, ozone, and lead.
Since 1970 there have been hundreds of
published studies that have evaluated the
health effects ofthese air pollutants. A 1996
review of the health effects of these criteria
pollutants (along with two other common
pollutants) was prepared by the Committee of
the Environmental and Occupational Health
Assembly ofthe American Thoracic Society
(ATS) (2). There have also been numerous
recent reviews that have focused on health
effects ofparticulate air pollution (3-14).
This article does not attempt to replicate the
excellent ATS review of all the criteria
pollutants or previous general reviews of
particulate air pollution. The overall plan of
this article is to focus on three basic topics.
First, the epidemiology ofthe health effects of
fine particulate air pollution PM2.5 (particles
< 2.5 pm) will be briefly summarized,
although recent, more comprehensive reviews
are available. This summary relies heavily on
updates of several previous reviews by
Dockery and Pope (6,8-11). Second, a some-
what speculative discussion ofthe early but
clearly incomplete contribution ofepidemiol-
ogy to evaluating the biologic mechanisms is
provided. This discussion ofbiologic mecha-
nisms is updated from papers originally pre-
pared for presentation at international
symposia (10,11). Finally, an original discus-
sion ofwho risks adverse health effects due to
exposure to fine particulate air pollution
is presented.
Characteristics of
Fine Particles
Particulate air pollution refers to an air-
suspended mixture ofsolid and liquid particles
that vary in size, composition, and origin. The
size distribution oftotal suspended particles
(TSPs) in the atmosphere is trimodal and
includes coarse particles, fine particles, and
ultrafine particles. Coarse particles (often
defined as thosewith an aerodynamic diameter
> 2.5 pm) are often naturally occurring and
derived primarily from soil and other crustal
materials. Fine particles (PM2,5) are derived
chiefly from combustion processes in trans-
portation, manufacturing, power generation,
etc. Sulfate and nitrate particles are commonly
generated by conversion from primary sulfur
and nitrogen oxide emissions, and a varying
portion ofsulfate and nitrate particles may be
acidic. Therefore, in most urban areas, PM2.5
mostly comprises primary combustion-source
particles as well as secondary combustion
particles including sulfates and nitrates.
Ultrafine particles are often defined as parti-
cles < 0.1 pm. These particles have relatively
short residence times in the atmosphere
because they accumulate or coagulate to
form larger fine particles.
Various physiologic and toxicologic
considerations suggest that exposure to fine
particles may be a health concern. Their size
is such that they can be breathed most deeply
in the lungs. They include sulfates, nitrates,
acids, metals, and carbon particles with vari-
ous chemicals adsorbed onto their surfaces.
Relative to coarse particles, they more readily
penetrate indoors, are transported over longer
distances, and are somewhat uniform within
communities, resulting in highly ubiquitous
exposure.
The initial reference method for meas-
uring particle concentrations and establishing
health standards in the United States was
TSPs. In 1987 the U.S. Environmental
Protection Agency (U.S. EPA) changed the
reference method to include only inhalable
particles. Inhalable particles refers to those
particles that can penetrate the thoracic air-
ways; for purposes ofstandard setting, inhal-
able particles were specifically defined as
particles < 10 pm in aerodynamic diameter
(PM1o). In 1997 the U.S. EPA promulgated
new standards (15) for an even finer cut of
particulate air pollution-particles < 2.5 pm
in aerodynamic diameter (PM2.5); however, in
May 1999, a U.S. Court ofAppeals blocked
the implementation ofthesestandards.
Health Effects of
Acute Exposure
The large majority ofepidemiologic studies of
particulate air pollution have been acute
exposure studies that evaluated short-term
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such as mortality counts, hospitalizations,
symptoms, and lung function associated with
short-term variations in levels ofpollution. A
brief summary of the results of these acute
exposure studies is presented in Table 1.
Unfortunately, until recently (following the
promulgation ofthe new PM2.5 standards),
there has been very little daily monitoring of
fine partides, and most ofthe studies summa-
rized in Table 1 used alternative measures of
particulate concentrations.
EpisodeStudies
The earliest and most methodologically
simple epidemiologic studies are those that
evaluate air pollution episodes. These studies
compare mortality (and morbidity) before,
during, and after pollution episodes. In
December of 1930 in the Meuse Valley,
Belgium, in October of 1948 in Donora,
Pennsylvania, and in December of 1952 in
London, England, stagnant air masses
resulted in marked increases in the concentra-
tions ofair pollutants. Although the biologic
mechanisms were not well understood, the
large excess mortality and morbidity associ-
ated with the extreme episodes clearly
demonstrated a link between mortality and
morbidity and air pollution. During these
episodes ofhighly stagnant air conditions, the
PM pollution would have been primarily
from combustion sources, and therefore PM
mass would have been mostly fine particles.
Two recent studies ofless severe air pollution
episodes (16,21) suggested smaller mortality
and morbidity effects associated with less
extreme pollution.
Mortality Counts
Many recent daily time-series mortality
studies have also observed changes in daily
death counts associated with short-term
changes in particulate air pollution, even at
relatively low or moderate concentrations
(Table 1). There have been more than 60 such
studies conducted in at least 35 cities. The rel-
ative risk ofmortality increased monotonically
with particulate concentrations, usually in a
linear or near-linear fashion. These studies did
not observe a particulate pollution health
effects threshold. In addition, these studies
often observed a lead-lag relationship between
Air nnliillinn incl mnrtAlitv- Thte rpf^RiiiR Rl C-11 FVXtSVXul Cdlu *sSVtLtCLXy. A lie ic
gested that the increased mortality
concurrently or within 1-5 days fol
Table 1. Summary ofepidemiologic evidence of health effects of acute exposure to particulate air polluti
Health end points
Episodes of
death and
hospitalizations
Mortality
Basic study design
Evaluate changes in mortality
and morbidity before, during,
and after pollution episodes.
Population-based time-series
studies that include statistical
time-series modeling to eval-
uate potential associations
with daily mortality counts.
Hospitalization Population-based time-
and other health- series studies that evaluate
care visits associations between
pollution and daily changes
in hospitalization and related
health-care end points.
Symptoms/ Panel-based time-series
lung function studies of symptom and/or
lung function data
repeatedly collected from
individuals in well-defined
panels or cohorts.
Observed associations with PM
Elevated respiratory and cardiovascular
mortality and hospitalizations.
Elevated daily respiratory and cardio-
vascular mortality counts. Effects persisted
with various approaches to control for
time trends, seasonality, and weather.
Near-linear associations with little
evidence of a threshold.
Elevated hospitalizations, emergency
visits, and clinic/outpatient visits for
respiratory and cardiovascular disease.
Effects generally persisted with various
approaches to control fortime trends,
seasonality, and weather.
Increased occurrence of lower respiratory
symptoms, cough, and exacerbation of asthma.
Only relatively weak associations with
upper respiratory symptoms. Small,
statistically significant declines in FEVo.75,
FEV1, or PEF, and increased occurrence of
clinically significant declines in lung function.
Abbreviations: FEVoy75, forced expiratory volume in 0.75 sec; FEV1, forced expiratory volume in 1 sec; PEF, peak expiratory
Table 2. Overall estimates of daily mortality effects of an increase in exposure to particulate air polluti
cause-of-death categories.
Cause-specific percent Percei
Percent of increase per 50 pg/m3 deal
Cause of death total deathsa increase inPM2.5a PM
All causesb 100 7.0
Respiratory 8 25.0
Cardiovascular 45 11.0
Otherdisease 47 0.4
'Based on updated summary estimates from previous reviews(6,8,10). bExcluding accidents, suicide, homicide, etc.
increase in air pollution. Because various
measurements ofparticulate pollution were
used in the different studies, and because vari-
ous modeling strategies were used, precise
comparisons ofeffect estimates across all the
studies were difficult. However, changes in
daily mortality associated with particulate air
pollution were typically estimated at approxi-
mately 0.5-1.5%/10 pg/m3 increase in PM1o
concentrations, or per about 5 or 6 pg/m3
increase inPM2.5 concentrations.
Studies that provided a breakdown of
mortality by broad cause-of-death categories
observed that particulate air pollution gener-
ally had the largest effect on respiratory and
cardiovascular disease mortality. Estimates of
daily mortality effects of an increase in expo-
sure to particulate air pollution by broad
cause-of-death categories are summarized in
Table 2. The estimated cause-specific
increase in mortality risk is much larger for
respiratory than for cardiovascular disease.
However, the percent of excess deaths attrib-
utable to particulate exposure is mostly due
to cardiovascular disease.
occurred Hospitalizations
lowing an Daily counts ofhospital admissions can be
analyzed in a manner similar to the assess-
ment ofdaily counts ofmortality. More than
50 daily time-series studies have reported
References associations between particulate air pollution
(16-21) and hospitalization or related health care end
points (Table 1). Most of these studies have
evaluated associations between respiratory
(22-66) hospital admissions and air pollution. Several
studies have also analyzed emergency depart-
ment visits for asthma, chronic obstructive
pulmonary disease, and other respiratory ail-
ments, and observed associations with partic-
(67-114) ulate air pollution. More recent studies have
observed associations between particulate air
pollution and hospitalizations for cardio-
vascular disease (73,74,87,98-100).
Symptoms/Lung Functon
(115152) There are more than 40 published studies
evaluating associations between daily respira-
tory symptoms and/or lung function and par-
ticulate air pollution (Table 1). Although
many ofthese studies focused on asthmatics
and exacerbation ofasthma, others followed
(flow. nonasthmatics and evaluated changes in acute
respiratory health status more generally.
ion by broad Small, often statistically insignificant, associa-
tions between particulate pollution and upper
ntof excess respiratory symptoms were observed.
ths due to Associations with lower respiratory symptoms
exposure and cough, however, were typically larger and
100 usually statistically significant. Exacerbation
28 ofasthma, based on recorded asthma attacks
69 or increased bronchodilator use, were also
3 associated with particulate air pollution.
Associations between more general measures
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ofacute disease have been studied, including
evaluations ofthe timing ofrestricted activity
days of U.S. adult workers due to illness
(131,132) and school absences in grade
school children (141).
Measures oflung function have also been
used as an objective and potentially sensitive
indicator ofacute response to air pollution.
Various studies have taken repeated measure-
ments ofthe lung function ofpanels ofchil-
dren and/or adults. These studies have
typically reported verysmall but often statisti-
cally significant decreases in lung function
associated with elevated levels ofparticulate
air pollution concentrations. Lagged effects of
up to 7 days were observed.
Effects ofChronic Exposure
The previously discussed acute exposure
studies indicate that short-term exposures to
elevated particulate air pollution are associ-
ated with short-term changes in cardio-
pulmonary health. These acute exposure
studies provide little information about how
much life is shortened, how pollution affects
longer-term mortality rates, or pollution's
potential role in the process of inducing
chronic disease that may or may not be life
threatening. Chronic exposure studies evalu-
ate health end points across communities or
neighborhoods with different levels ofaverage
pollution over longer time periods (usually 1
year or more). Chronic exposure studies
attempt to evaluate the effects oflow or mod-
erate exposure that persists forlong periods as
well as the cumulative effects of repeated
exposure to substantially elevated levels of
pollution. A briefsummary ofthe results of
the chronic exposure studies is provided in
Table 3.
MortalityRates
Several population-based, cross-sectional
mortality studies have evaluated associations
between annual mortality rates and particu-
late air pollution across U.S. metropolitan
areas (Table 3). The basic conclusions from
these population-based cross-sectional studies
were that mortality rates were associated with
air pollution, and they were most strongly
associated with fine or sulfate PM. Such asso-
ciations are illustrated in Figure 1. Age, sex,
and race-adjusted population-based mortality
rates for U.S. cities in 1980 are plotted over
various indices ofparticulate air pollution
[obtained from Lipfert et al. (158) and U.S.
EPA (163)]. Although much apparently sto-
chastic variability exists, adjusted mortality
rates are positively correlated with fine
(PM2 5) and sulfate particles but not with
TSPs. Multiple regression modeling tech-
niques to evaluate cross-sectional differences
in air pollution and mortality and to control
for other ecologic variables have been used.
Whereas the population-based cross-sectional
studies from the United States dealt with
total mortality, a study from the Czech
Republic focused on infant mortality (154).
Infant mortality, especially respiratory post-
neonatal infant mortality, was strongly associ-
ated with particulate air pollution. All of
these population-based cross-sectional
Table3. Summary of epidemiologic evidence ofhealth effects ofchronic exposure to particulate air pollution.
Health Observed associations
end points Basic study design with particulate pollution References
Mortality Population-based cross-sectional Higher mortality in areaswith higherfine (153-160)
rates analysis of mortality rates across particulate and/orsulfate pollution levels.
communities with different levels Pollution effect sensitive to model
of pollution. specification and choice ofcovariates
included inthe analysis.
Survival/life Cohort-based cross-sectional studies Increased risk of respiratory and cardio- (161-164)
expectancy that linkcommunity-based air vascular mortality in adults, and respira-
pollution data with individual risk- toryand sudden infantdeath syndrome
factorand survival data. mortality in infants, even aftercontrolling
for individual differences in cigarette
smoking and various other riskfactors.
Disease Cross-sectional studies ofcommunity Increased chronic cough, bronchitis, (165-170)
airpollution with individual symptom/ and chest illness(but notasthma).
disease data from surveys orcollected
cohorts.
Lung Cross-sectional studies ofcommunity Particulate airpollution associated with (171-176)
function ambient air pollution data with small but often statistically significant
individual lungfunction data from declines in various measures of lung
national surveys orcollected cohorts. function in both children and adults.
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Figure 1. Age-, sex-, and race-adjusted population-based mortality rates in U.S. cities for 1980 plotted over various
indices ofparticulate air pollution.
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Table 4. Comparisons ofmortality risk ratios (and 95% confidence interval) forair pollution from the Harvard Six-Cities, ACS, and postneonatal infant mortality studies.
Particulate airpollution (range of pollution)
AHSMOG AHSMOG
Six-Cities ACS ACS Infant (males) (females)
Cause ofdeath (18.6 pg/M3 PM25) (24.5 pg/M3 PM25) (19.9 pg/M3 S04) (56.9 pg/M3PM10) (24.1 pg/M3PM10) (24.1 pg/M3PM1O)
All 1.26(1.08-1.47) 1.17 (1.09-1.26) 1.15(1.09-1.22) 1.25(1.12-1.47) 1.11 (0.98-1.26) 0.94(0.84-1.04)
Cardiopulmonary 1.37 (1.11-1.68) 1.31(1.17-1.46) 1.26(1.16-1.37) 1.10(0.94-1.30) 0.92(0.80-1.05)
Respiratory mentioneda - 1.23(0.94-1.61) 1.10(0.86-1.40)
SIDS, NBW 1.91 (1.46-2.44)
Lung cancer 1.37(0.81-2.31) 1.03 (0.80-1.33) 1.36(1.11-1.66) 3.36(1.57-7.19) 1.33(0.60-2.96)
All others 1.01 (0.79-1.30) 1.07 (0.92-1.24) 1.01 (0.92-1.11) 1 00b(0.94-1.06)
Abbreviations: NBW, normal birth weight; PM, particulate matter; SIDS, sudden infant deathsyndrome.
'Any mention onthedeath certificate ofnonmalignant respiratory disease as an underlying orcontributing cause ofdeath. hNBW.
mortality studies have severe limitations and
have been discounted for several reasons. An
overriding concern is that they cannot
directly control for individual differences in
other important risk factors including
cigarette smoking.
SurivaL Expectncy
Several cohort-based mortality studies have
evaluated effects oflong-term pollution expo-
sure. The first ofthese studies, often referred
to as the Harvard Six-Cities study (162),
involved a 14- to 16-year prospective
follow-up ofmore than 8,000 adults living in
six U.S. cities. It controlled for individual dif-
ferences in age, sex, cigarette smoking, educa-
tion levels, body mass index, and other risk
factors. Cardiopulmonary mortality was sig-
nificantly associated with mean sulfate and
fine particulate concentrations over the years
ofthe studyperiod.
A second study, referred to as the ACS
study, linked individual risk factor data from
the American Cancer Society, Cancer
Prevention Study II (CPS-II) with national
ambient air pollution data (163). The analy-
sis used data for more than 500,000 persons
who lived in up to 151 different U.S. metro-
politan areas and who were followed
prospectively from 1982 through 1989. It
controlled for individual differences in age,
sex, race, cigarette smoking, and other risk
factors, and evaluated the association of
adjusted mortality with two indices oflong-
term exposure to combustion-source particu-
late air pollution, mean sulfate, and median
fine particles. Both indices ofcombustion-
source particulate air pollution were associ-
ated with overall mortality and especially
with cardiopulmonary mortality.
In both the Harvard Six-Cities study (162)
and theACS study (163), the positive associa-
tion between combustion-related air pollution
and cardiopulmonary mortalitywas dominated
by cardiovascular disease deaths. However,
because ofconcerns aboutcause-of-death cross-
coding on the death certificates, respiratory and
cardiovascular deaths were grouped together
andanalyzed ascardiopulmonary deaths.
A study ofpostneonatal infant mortality
in the U.S.-linked National Center for
Health Statistics birth and death records for
infants born between 1989 and 1991 with
PM1o data from the U.S. EPA's Aerometric
Database (164). The full data set included
approximately four million infants in 86 U.S.
metropolitan areas. Because all infants in the
study had PM1o exposure for at least part of
2 months, the analysis compared postneona-
tal infant mortality across different levels of
ambient PMto concentrations during the
2 months following birth. The analysis con-
trolled for individual differences in maternal
race, maternal education, marital status,
month of birth, maternal smoking during
pregnancy, and ambient temperatures.
Particulate pollution exposure was associated
with postneonatal infant mortality for all
causes, respiratory causes, and sudden infant
death syndrome.
A final cohort study, known as
the Adventist Health Study of Smog
(AHSMOG), related air pollution to
1977-1992 mortality in more than 6,000
nonsmoking adults living in California, pre-
dominantly from the three metropolitan areas
ofSan Diego, LosAngeles, and San Francisco
(161). All natural cause mortalities, non-
malignant respiratory mortalities, and lung
cancer mortalities were significantly associ-
ated with ambient PM1o concentrations in
males, but not in females. Cardiopulmonary
disease mortality was not significantly associ-
ated with PM1o in either males or females.
Unfortunately, this study did not have direct
measures ofPM2.5 but relied on TSP and
PM1o data. Furthermore, the cohortwas rela-
tivelysmall andwas predominantly from only
three metropolitan areas, San Diego, Los
Angeles, and San Francisco.
Comparisons ofmortality risk ratios for
air pollution from the Six-Cities, ACS, infant
mortality, and AHSMOG studies are pre-
sented in Table 4. The estimated overall
excess risk from the infant mortality study is
similar to those estimated for adults in the
Harvard Six-Cities and ACS studies, even
though the time frame ofexposure for the
infants was clearly far shorter than for the
adults. This observation suggests that the rele-
vant time frame ofexposure is short (a few
months vs years) and/or that infants are at
greater riskforexposure to airpollution.
Disea LungFunction
There have also been several studies evaluating
associations between chronic exposure and
particulate air pollution and respiratory
symptoms and disease or lung function
(Table 3). The effects ofair pollution on res-
piratory disease or symptoms were often esti-
mated while adjusting for individual
differences in various other risk factors.
Significant associations between particulate
air pollution and various respiratory symp-
toms were often observed. Chronic cough,
bronchitis, and chest illness (but not asthma)
were associated with various measures ofpar-
ticulate air pollution. Studies that evaluated
effects of air pollution on lung function
adjusted for individual differences in age,
race, sex, height, and weight, and controlled
for smoking or restricted the analysis to
never-smokers. These studies observed small
associations between decreased lung function
and particulate air pollution that were often
statisticallysignificant.
StylizdSummaryofEffects
The overall epidemiologic evidence is
enhanced ifadverse effects ofexposure are
reproducibly observed by different investiga-
tors in different settings. That is, there should
be consistency ofeffects across independent
studies. The evidence is further strengthened
by a coherence ofeffects observed across a
cascade ofrelated health outcomes. Figure 2
presents a stylized summary of effect esti-
mates ofexposure to particulate air pollution.
The effect estimates are not precise because
different studies usedvarious measures ofpol-
lution, different models, and differently
defined health end points. In addition, the
recent rapid growth ofthe literature in this
area makes effect estimates a moving target.
Figure 2, therefore, should be considered
stylized but illustrative. The estimates for the
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acute time-series studies are revised from
recent reviews (6,8). The effect estimates for
the cross-sectional and cohort studies are
based on selected studies that are reasonably
representative. The population-based mortal-
ity estimate is based on results presented by
Evans et al. (155), Lipfert (157), Lipfert et al.
(158), and Ozkaynak and Thurston (160).
The cohort-based mortality estimates are
based on Dockery et al. (162), Pope et al.
(163), and Woodruff et al. (164), respec-
tively. Bronchitis, children's lung function,
and adult lung function estimates are based
on results reported by Dockery et al. (167),
Raizenne et al. (173), and Ackermann-
Liebrich et al. (171), respectively.
As illustrated in Figure 2, a remarkable
cascade ofcardiopulmonary health end points
has been observed. These include death from
cardiac and pulmonary disease, emergency
room and physician office visits for asthma
and other cardiorespiratory disorders, hospi-
tal admissions for cardiopulmonary disease,
increased reported respiratory symptoms,
and decreased measured lung function. The
overall epidemiologic evidence indicates a
probable link between fine particulate air
pollution and adverse effects on cardio-
pulmonary health. Nevertheless, there
remains uncertainty about the role ofchem-
istry versus size ofthe particles, the role of
copollutants, and the use ofcentral-site air
quality monitoring to estimate the effects on
individuals who spend most oftheir time
indoors. In addition, there remains substan-
tial uncertainty with regard to the biologic
plausibility ofthese associations.
What Arethe Biologic
Mechanisms?
Ourknowledge about the underlying biologic
mechanisms remains limited and requires
much additional study. The results ofthe epi-
demiology outlined above, however, provide
a pattern ofeffects that may be biologically
germane. Biologic plausibility is enhanced by
the observation of a coherent cascade of
cardiopulmonary health effects and by the
fact that noncardiopulmonary health end
points are not typically associated with the
pollution. In addition, as summarized in
Table 5, very recent epidemiologic studies
have attempted to look at specific physiologic
end points, in addition to lung function, that
may be part ofthe pathophysiologic pathway
linking cardiopulmonary mortality and
particulate airpollution.
One hypothesized general pathway
includes pollution-induced lung damage
(potentially including oxidative lung damage
and inflammation), declines in lung function,
respiratory distress, and cardiovascular disease
potentially related to hypoxemia (177).
Evidence ofpollution-related inflammation
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Figure 2. Stylized summary of observed health effects, presented as approximate percent changes in health end
points per 5 pg/m3 increase in PM2.5. Abbreviations: COPD, chronic obstructive pulmonary disease; FVC, forced vital
capacity; PEF, peak expiratory flow. Asterisk(*) indicates estimate based on very limited or inconsistent evidence.
Table 5. Brief summary ofseveral recent epidemiologic studies of specific physiologic end points.
Physiologic Observed associations with
end points elevated particulate matter exposure Authors/year (reference)
Lung function Small declines in lung function; large risk of substantial decrements Hoek etal. 1999(125)
Hypoxemia No clear associations with blood oxygen saturation Pope et al. 19991177)
Plasmaviscosity Increased risk of elevated blood plasma viscosity Peters et al. 1997 1178)
Heart rate Increased mean HR and odds of a substantially elevated HR. Pope etal. 1999(177)
Peters etal.1999(179)
Heart rate Changes in cardiac rhythm. Decrease in overall HRV. Liao et al. 1999(180)
variability Pope etal. 1999)181)
Gold etal. 2000(182)
Pulmonary Elevated white blood cell counts, band cells expressed as percentage Tan et al. 2000(183)
inflammation ofpolymorphonuclear leukocytes, platelets, lymphocytes, and eosinophils Salvi et al. 1999(184)a
'This is actually a controlled human exposure study.
has been observed (183-185) and, as indicated
above, several studies have reported declines
in lung function associated with elevated par-
ticulate pollution exposures. However, a
study ofpotential PM-related hypoxemia did
not observe declines in blood oxygen satura-
tion associated with elevated exposures to
particulate airpollution (177).
Alternatively, the autonomic nervous
system may play an important role in the
pathophysiologic pathway between particu-
late exposure and cardiopulmonary disease.
Seaton et al. (186) hypothesized that fine
particulate air pollution may provoke alveolar
inflammation, resulting in the release of
potentially harmful cytokines and increased
blood coagulability. Autonomic nervous
system-activated changes in blood viscosity,
heart rate (HR), and heart rate variability
(HRV) may increase the likelihood ofcardiac
death (187). A few recent epidemiologic
studies (177-183) have evaluated such auto-
nomic nervous system-related physiologic
measures and air pollution, although they
have been extremely limited and mostly
exploratorypilotstudies.
Peters et al. (178) evaluated blood plasma
viscosity from a random sample ofmen and
women living in Augsburg, Germany, during
the winter of1984-1985. Between January 4
and 7, 1985, there was a pollution episode
with marked increases in sulfur oxide and
particulate pollution concentrations. During
this episode a significant increase in the risk
of elevated plasma viscosity was observed.
The odds ratios (and 95% confidence inter-
vals [CIs]) for plasmaviscosity were above the
95th percentile of the sample distribution;
they were 3.6 (1.6-8.1) and 2.3 (1.0-5.3) for
men andwomen, respectively.
A daily time-series panel study ofelderly
subjects with repeated measures of blood
oxygenation did not observe pollution-related
hypoxemia but did observe that elevated par-
ticulate air pollution levels were associated
with increased pulse rate (177). A 100-mg/m3
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increase in PM1o on the previous 1-5 days
was associated with an average increase in the
pulse rate of0.8 beats/min and a 29% and
95% increase in the odds of the pulse rate
being elevated by 5 or 10 beats/min, respec-
tively.
In a related study (181), repeated 24-hr
ambulatory electrocardiograph (ECG) moni-
toring was conducted on seven subjects for a
total of29 days during episodes ofhigh pol-
lution and during periods ofrelatively low
pollution. HR was positively associated with
particulate air pollution. Additionally, beat-
to-beat (R-R) HRV was analyzed to assess
cardiac autonomic control. Particulate air
pollution was associated with changes in
HRV including: reduced 24-hr SDNN (the
standard deviation ofall normal R-R inter-
vals and an estimate of overall HRV);
reduced SDANN (standard deviation ofthe
averages of R-R intervals in all 5-min seg-
ments ofthe 24-hr ECG recording and an
estimate oflong-term components ofHRV);
and increased r-MSSD (the square root of
the mean ofsquared differences between
adjacent R-R intervals and an estimate ofthe
short-term components ofHRV). The asso-
ciations between HRV and particulate pollu-
tion persisted even after controlling for mean
HR, suggesting a possible link between ele-
vated exposure to PM and lower cardiac
autonomic control.
Aprospective study ofHRVand mortality
in subjects with chronic heart failure was
recently reported (187). Survival analysis
conducted in this study included a Cox
Proportional Hazards regression model to
control for multiple riskfactors. Based on this
model the estimated risk ratio for a 41.2-ms
decrease in SDNN (from 24-hr ambulatory
ECG monitoring) was 1.62 (95% CI,
1.16-2.44). As an interesting but highlyspec-
ulative look at plausibility, the 24-hr SDNN
mortality relationship from this study can be
combined with the decline in 24-hr SDNN
associated with PM1o from the above HRV
study (181). The expected increase in mortal-
ity risk can then be estimated and compared
with the PM-related cardiovascular mortality
risk directly estimated from the PM mortality
epidemiology studies. For example, the esti-
mated decline in 24-hr SDNN associated
with 100 pg/m3 PM1o was approximately
18 ms (SE = 4.9). Using the coefficients
reported in these two studies (181,187), the
estimated mortality risk ratio ofan 18-ms
decline in 24-hr SDNN can be calculated as
1.23 (e[l8*(lnl.62)/4.2]). This risk ratio seems
somewhat plausible. It is larger than riskratios
for total or cardiovascular disease mortality
that are generally estimated from daily time-
series studies but smaller than risk ratios esti-
mated from the prospective cohort mortality
studies oflong-term chronicexposure.
Two additional studies have also recently
evaluated associations between particulate air
pollution and HRV. One ofthese studies
explored daily changes in HRV associated
with daily changes in fine particulate air pol-
lution with a panel ofelderly subjects living
in metropolitan Baltimore (180). Daily ECG
monitoring was conducted with resting,
supine, 6-min R-R interval data collected
each day. The second study involved subjects
53-87 years of age living in Boston,
Massachusetts (182). Weekly ECG monitor-
ingwas conducted using ambulatory (Holter)
monitors continuously for 25 min, including
5 min ofrest, 5 min ofstanding, 5 min of
outdoor exercise, 5 min ofrecovery, and 20
cycles ofslow breathing. Although the pollu-
tion levels were relatively low during the
study periods in both ofthese studies, lower
HRVwas associated with elevated concentra-
tions offine particulate pollution, and the
association was stronger for subjects with
pre-existing cardiovascularconditions.
In the three currently available studies
of particulate air pollution and HRV
(180-182), a negative association with par-
ticulate exposure and overall HRV was
observed. The results, however, are not
entirely consistent, especially with measures
ofthe short-term (or high-frequency) compo-
nents ofHRV. To what degree these incon-
sistencies across studies can be explained by
differences in ECG monitoring time frames,
make-up ofsubjects, differences in pollution
levels, or other differences needs to be
explored.
A study ofrabbits found that alveolar
macrophage phagocytosis ofsmall carbon par-
ticles < 10 pm in aerodynamic diameter
resulted in the release ofcytokines that led to
stimulation ofthe bone marrow to release
young polymorphonuclear leukocytes
(PMNs). The authors postulated that these
PMNs caused the health effects noted in epi-
demiologic studies (188). A follow-up study
was conducted ofan air pollution episode due
to fires in SoutheastAsia in 1997 (183). Blood
samples from 30 healthy male military person-
nelwere collectedduringandafter theepisode.
The pollution episode was associated with sig-
nificant increases in total white blood cell
counts, band cells expressed as a percentage of
PMNs, platelets, lymphocytes, and eosino-
phils. The authors suggest that these results
imply a systemic response to PM-related pul-
monary inflammation. A recent controlled
human studyofexposure to diesel exhaust also
observed a well-defined and marked systemic
and pulmonary inflammatory response in
healthyhumanvolunteers (184).
The physiologic relevance of no PM-
related hypoxemia but PM-related changes in
blood plasma viscosity, HR, HRV, and pul-
monary inflammation is not well understood.
Recent animal studies have observed some-
what complementary results (188-194), but
the epidemiologic observations are prelimi-
nary and based on only a few studies, most of
which were exploratory pilot studies. These
changes may reflect PM-induced pulmonary
inflammation, cytokine release, and altered
cardiac autonomic function as part of the
pathophysiologic mechanisms or pathways
linking PM and cardiovascular mortality. In
general, it is speculated that interactions
between inflammation, abnormal hemostatic
function, and altered cardiac rhythm may
play an important role in the pathogenesis of
cardiopulmonary diseases related to air pollu-
tion. An adequate understanding ofthese
relationships clearly requires further research.
Who's at Risk?
The question ofwho is at risk or who is
susceptible to adverse health effects offine
PM pollution does not have an easy answer.
It seems evident that the elderly, young chil-
dren, and persons with chronic cardio-
pulmonary disease, influenza, and asthma are
most likely to be susceptible. However, this
answer is far too simplistic. For example,
assume a large population of nonsmokers.
Require all in the population to smoke apack
ofcigarettes for a day and then stop. Who
will be susceptible to this relativelyshort-term
exposure to cigarette smoking? Mortality and
serious morbidity effects would most likely
affect the very old, young, and those with
asthma or chronic cardiopulmonary disease.
This does not mean that others are un-
affected. For healthy, middle-aged adults, the
effects are unlikely to be immediately life
threatening, but short-term adverse effects
such as coughing, throat and eye irritation, or
even mild or moderate cigarette smoke-
induced pulmonary inflammation may be
experienced. Further suppose smoking does
not stop after 1 daybut continues throughout
the lives ofall in the population. Nowwho is
susceptible to exposure to cigarette smoke?
Over a lifetime, the chronic exposure has the
potential to eventually effect all. Although the
exposures and effects for active cigarette
smoking are much larger, cigarette smoking
has been associated with a spectrum ofcar-
diopulmonary diseases similar to those associ-
atedwith fine PM. Interestingly, adecrease in
HR and an increase in HRV have also been
observed following smoking cessation (195).
Clearly, the answer to the question ofwho is
susceptible is not simple but is dependent on
the health effects being evaluated and the
level and length ofexposure.
AtRiskfiomShort-Term,
AcuteExposure
A summary ofwho may be susceptible to
various adverse health effects from PM
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exposure and overall health relevance is
presented in Table 6. With respect to acutely
elevated exposures, reflected by day-to-day
changes in PM, those susceptible to dying are
the elderly, the very young, and persons with
chronic cardiopulmonary disease, influenza,
or asthma. During the London episode of
1952, for example, approximately 80-90% of
the excess deaths were in adults with respira-
tory and/or cardiovascular disease that was
generally chronic in nature. Therewas also an
approximate doubling ofdeaths in children
less than 1 year ofage (20). As summarized
in Table 2, more recent daily time-series
studies also observe that most ofthe excess
mortality from PM exposure is from respira-
tory and cardiovascular disease deaths.
How much life shortening is due to
acutely elevated levels ofPM and how much
ofthe mortality is due to short-term mortality
displacement (harvesting) remains uncertain.
Ifthe increased mortality is only in the most
frail persons with little remaining life
expectancy, then death may be advanced by
only a few days or weeks. However, recent
research using data from Philadelphia,
Pennsylvania observed that the increase in
mortality was inconsistent with only short-
term mortality displacement and suggests that
mortality for many may be substantially
advanced (196). These results also suggest
that those who are susceptible to increased
risk of mortality from acutely elevated PM
may include more than just the most old and
frail who are alreadyvery neardeath.
On any given day, the number dying due
to PM exposure is extremely small. Based on
the 1996 average death rate for the United
States (8.8/1000/year) and the summary esti-
mates presented in Table 2, a 50-,ug/m3
increase in PM2.5 would result in an average
ofonly 1.7 deaths per day per one million
people (compared to an expected rate of
approximately 24/day). This minimal excess
deaths per day reflects the fact that the
increased risk ofmortality due to acutely ele-
vated PM exposure is small, and on anygiven
day there may only be avery small fraction of
the population at serious risk ofdying due to
this acute exposure.
As summarized in Table 6, the number of
those susceptible to being hospitalized
because ofacute PM exposure is probably
also quite limited and similar to the number
ofthose at risk ofdying. However, the num-
ber ofthose susceptible to less serious health
effects such as increased respiratory symp-
toms, decreased lung function, or other phys-
iologic changes may be quite broad. For most
people, these effects are likelysmall, transient,
and maybe even unnoticed. For a few, the
decline in lung function may be clinically rel-
evant (125), or the effects may be result in
short-term absence from work (131,132) or
school (141).
AtRiskfromLong-Term
Chronic posure
Long-term, repeated PM exposure has been
associated with increased population-based
mortality rates (155-160) as well as increased
risk of mortality in broad-based cohorts or
samples of adults (162,163) and children
(164) (Table 4). Chronic exposure studies of
PM suggest rather broad susceptibility to
cumulative effects of long-term repeated
exposure. There is no evidence that increased
mortality risk is unique to any well-defined
susceptible subgroup. All who are chronically
exposed mayultimately be affected. However,
because the relative risk is small, the long-
term cumulative effects are most likely to be
observed in older age groups with relatively
higher baseline risks ofmortality.
To illustrate the potential cumulative
mortality effects ofPM, survival curves and life
expectancies have been estimated under six dif-
ferent scenarios illustrated in Figure 3. The first
curve is a baseline survival curve based on pro-
jected U.S. life tables prepared by the Office of
the ChiefActuary in the Social Security
Administration andobtainedfrom theBerkeley
Mortality Database (197). Although a survival
curve for never-smokers and for persons not
exposed to urban air pollution was not directly
calculated, this projected baseline curve is used
to represent a reasonable baseline estimate for
the total U.S. population. The life expectancy
ofthis baselinecurveisequal to 76.4years.
The second, third, and fourth survival
curves are calculated from the baseline curve
assuming an additional relative riskofmortal-
ity from PM exposure equal to 1.25. This is
approximately the relative risk estimated in
both the Harvard Six-Cities study (162) and
the postneonatal infant mortalitystudy (164)
for the relevant range of PM air pollution
that exists in U.S. urban areas (Table 4). The
only difference between the second, third,
and fourth curves is the age at which people
begin to be susceptible to the effects ofpollu-
tion. Curves two, three, and four assume that
susceptibility begins at age 45 years, age 1
year, and at birth, respectively. As can be seen
in Figure 3, these three survival curves appear
to be nearly identical. The close concurrence
between these three curves is because the
baseline mortality risk for infants, children,
and young adults is so low compared to the
baseline mortality risks for older adults. The
estimated life expectancy for curves two,
three, and four equal 73.9, 73.5, and 73.4
years, respectively. This suggests an average
loss oflife expectancy equal to 2.5, 2.9, and
3.1 years, respectively. Obviously, earlier
onset ages ofsusceptibility result in greater
Table 6. Summary ofwho's susceptible to adverse health effects from PM exposure and overall health relevance.
Health effects Who's susceptible? Overall health relevance
Acute exposure
Mortality Elderly, infants, persons with chronic Obviously relevant. How much life shortening is involved and how much
cardiopulmonarydisease, influenza, orasthma is due to short-term mortalitydisplacement (harvesting) is uncertain.
Hospitalization/ other Elderly, infants, persons with chronic cardiopulmonary Reflects substantive health impacts in terms of illness, discomfort,
health care visits disease, pneumonia, influenza, orasthma treatment costs, work or school time lost, etc.
Increased respiratory Mostconsistently observed in people with asthma Mostly transient effects with minimal overall health consequence,
symptoms and children although for a fewthere may be short-term absence from work or
school due to illness.
Decreased lung function Observed in both children and adults For most, effects seem to be small and transient. For afew, lung function
losses may beclinically relevant.
Plasma viscosity, heart rate, Observed in both healthy and unhealthy adults. No Effects seem to be small and transient. Overall health relevance
heart rate variability, studies of children is unclear, but may be part of pathophysiologic pathway linking
pulmonary inflammation PM withcardiopulmonary mortality.
Chronic exposure
Increased mortality rates, Observed in broad-based cohorts orsamples of Long-term, repeated exposure appears to increase the risk of cardio-
reduced survival times, chronic adults and children (including infants). All pulmonary disease and mortality. May result in lower lung function.
cardiopulmonary disease, chronicallyexposed potentially are affected Population average loss of life expectancy in highly polluted cities
reduced lung function may be as much as a fewyears.
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Figure 3. Survival curves based on projected U.S. life tables and alternative excess risk assumptions. Abbreviation:
RR, relative risk.
overall loss oflife. Differences in assumptions
about the age when susceptibility begins,
however, make only small differences for the
younger ages because of the relatively low
baseline mortality risks.
Survival curve five in Figure 3 was calcu-
lated from the baseline curve assuming an
additional relative riskofmortality from ciga-
rette smoking from age 20 equal to 2.00.
This is approximately the average relative risk
ofapproximately average levels ofsmoking
versus never smoking that was estimated in
both the Harvard Six-Cities study (162) and
the ACS study (163). The estimated average
life expectancy for smokers was 67.9, a loss of
life expectancy equal to 8.6 years. Clearly,
.cigarette smoking has a much larger impact
on mortality than ambient air pollution.
However, this estimate of loss of life
expectancy is not a population average, but
the average loss to smokers only.
The sixth curve was calculated from the
baseline curve assuming an additional rela-
tive risk of mortality from PM exposure
equal to only 1.15. This is approximately
the relative risk that was estimated from the
ACS study (163) for the relevant range of
PM air pollution in the United States
(Table 4). Susceptibility was assumed to
begin after infancy at age 1 year. The esti-
mated life expectancy was 74.6, a loss oflife
expectancy equal to 1.8 years. These results
are comparable to those obtained from two
similar analyses (198,199).
Although the elevated risk associated with
particulate air pollution exposure is relatively
small compared with cigarette smoking, the
public health significance offine particulate air
pollution, at least as measured in population
average loss oflife, is substantial for two basic
reasons. Exposure is ubiquitous. Because fine
particles areoften generated indoors and ambi-
ent fine particles penetrate many indoor envi-
ronments, essentially everyone is exposed.
Furthermore, exposure is not avoluntary deci-
sion made as a teenager or in adulthood but
occurs throughoutlife.
The above estimates ofpopulation aver-
age life lost from the pollution are probably a
worst-case scenario for the United States.
They use relatively large estimates ofexcess
risk from chronic exposure to pollution from
the recent prospective cohort studies ofadults
and the postneonatal infant mortality study.
They assume that the risk effects are cumula-
tive for all or alarge partofpersons' lives, and
they assume lifelong residency in one ofthe
most polluted U.S. cities. Loss oflife esti-
mates due to pollution exposure of 1-3 years
for lifelong residents ofhighly polluted cities,
however, is not unreasonable, especially in
some ofthe more polluted cities in theworld.
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